William Hu, MD, PhD, FAAN, a neurologist at RWJBarnabas Health’s Robert Wood Johnson University Hospital in New Brunswick, NJ, shared new advances to detect and treat Alzheimer disease.
A duo of experts discussed the importance of addressing barriers such as provider comfort, access to genetic counselors, and insurance coverage to reduce diagnostic latency and standardize genetic testing for epilepsy. [WATCH TIME: 5 minutes]
The director of disability policy at the Muscular Dystrophy Association talked about the future possibility of having an aircraft that accommodates for patients with neuromuscular disorders who use mobility devices. [WATCH TIME: 3 minutes]
The chief medical research officer and head of research at Aviv Clinics talked about the anticipation of long-term results on a randomized controlled trial assessing hyperbaric oxygen therapy, a treatment for long COVID. [WATCH TIME: 5 minutes]
The director of the Joseph Epstein Center for Emergency Medicine Research discussed whether years of experience causes variation in the way migraine is diagnosed and treated in an emergency department setting. [WATCH TIME: 2 minutes]
The nurse practitioner at the University of Southern California Keck Medical School provided insight on steps before deep brain stimulation and how they can impact outcomes for patients with Parkinson disease. [WATCH TIME: 4 minutes]
The professor of neurology at University of Colorado School of Medicine discussed the evolving landscape of MS treatment, highlighting the role of personalized medicine and biomarker-driven decision-making. [WATCH TIME: 5 minutes]
With promising names like "5-Minute Neurology Consult" and "Neurosurgery Survival Guide" the mobile applications in this top-pick list provide immediate and encyclopedic access to the nuts, bolts, and nuances of neurologic practice.
Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.
Take a look at these 3 images and see if you can pinpoint the cause of altered consciousness in this woman.
The associate professor of neurology at Mayo Clinic College of Medicine discussed findings from a post-hoc analysis of the phase 3 PREVAIL study presented at AHS 2024 assessing eptinezumab in patients with chronic migraine. [WATCH TIME: 4 minutes]
Neurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article.
What’s in your differential diagnosis for this cachectic, disheveled patient who can no longer carry on a coherent conversation?
A 20-year-old woman had a Caesarian section at 39 weeks. She had a history of migraine, but this headache was different. Her request for “something really strong” for the pain was cause for concern.
There is a pressing need for effective interventions aimed at enhancing psychological well-being and self-management for epilepsy patients.
In this podcast, Ann Scher, PhD, lead author in a recently published study, gives a succinct overview of the details and briefly discusses what the findings may suggest.
The HypnoLaus study compared sleep characteristics of individuals older than 65 years of age with and without cognitive impairment.
Does smell identification have any predictive value for later Alzheimer disease?
The section chief of pediatric neurology at Nationwide Children’s Hospital discussed cannabidiol's potential in the Lennox-Gastaut syndrome space.
Inquiring about memory in older persons during routine clinical examination may identify persons who might be at higher risk for stroke.
The associate vice president of neuroscience, US Medical Affairs at Eli Lilly talked about the "Think Talk Treat Migraine" program and the 3 vital actions for providers take to improve migraine care for their patients. [WATCH TIME: 3 minutes]
Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.
A large study may bring us closer to identifying interventions that can help the homeless population with neurologic disease.
A sudden severe headache with emesis brings a 35-year-old man to the ED. Research on his smart phone has satisfied him that this is a post-coital event and therefore, harmless. He refuses a lumbar puncture.
There is no approved screening tool for misophonia, but a case review can lead to a diagnosis. Several treatment options may aid in symptom management.
Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.
Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.